The prevalent dogma has been that the main players of MS contributing to the inflammatory component of the pathogenesis of the disease are autoreactive CD4+ T helper (Th) cells, key participants of the adaptive immune response activated against a wide range of pathogens. This evidence concerns the gene CD4 and myeloid sarcoma.